MK 212盐酸盐 | 64022-27-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 中文名称: MK 212盐酸盐
• 中文别名: 6-氯-2-(1-哌嗪基)吡嗪；MK212盐酸盐；2-氯-6-哌嗪吡嗪
• 英文名称: 6-chloro-2-(1-piperazinyl)pyrazine
• 英文别名: 2-chloro-6-(1-piperazinyl)pyrazine；MK 212；6'-chloro-3,4,5,6-tetrahydro-2H-[1,2']bipyrazinyl；1-(6-chloro-2-pyrazinyl)piperazine；MK-212；(6-chloro-2-pyrazinyl)piperazine；2-chloro-6-piperazin-1-ylpyrazine
• CAS: 64022-27-1
• 化学式: C₈H₁₁ClN₄
• 分子量: 198.655
• InChiKey: CJAWPFJGFFNXQI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  41
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 海关编码：
  2933990090
• 危险性防范说明：
  P280,P305+P351+P338
• 危险性描述：
  H317,H319
• 储存条件：
  2-8°C

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Chloro-6-(1-piperazinyl)pyrazine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Chloro-6-(1-piperazinyl)pyrazine
CAS number: 64022-27-1

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H11ClN4
Molecular weight: 198.7

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

MK-212(CPP)是一种具有中枢作用的5-HT1C/5-HT2受体激动剂，能够刺激大脑皮层中的磷脂酰肌醇水解[1]。

反应信息

• 作为反应物：
  描述：

  MK 212盐酸盐 在 bis-triphenylphosphine-palladium(II) chloride 、 sodium carbonate 作用下， 以 1,4-二氧六环 、 水 、 乙腈 为溶剂， 反应 24.25h， 生成 2-[4-[6-(2,3-dihydro-1-benzofuran-5-yl)pyrazin-2-yl]piperazin-1-yl]-N-propan-2-ylacetamide
  参考文献：
  名称：

  NOVEL NITROGEN-CONTAINING AROMATIC HETEROCYCLIC COMPOUND

  摘要：

  公开号：

  EP3381904B1
• 作为产物：
  描述：

  6’-氯-2,3,5,6-四氢-[1,2’]联吡啶-4-羧酸叔丁酯 在 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 反应 3.5h， 以289 mg的产率得到MK 212盐酸盐
  参考文献：
  名称：

  NOVEL NITROGEN-CONTAINING AROMATIC HETEROCYCLIC COMPOUND

  摘要：

  公开号：

  EP3381904B1

文献信息

• Benzoxazepine derivative
  申请人：Suntory Limited

  公开号：US05071845A1

  公开（公告）日：1991-12-10

  A benzoxazepine derivative suitable for use as a psychotropic composition having the formula: ##STR1## wherein A and B are both carbonyl groups, or one thereof represents a methylene group and the other a carbonyl group, R represents an aromatic group or a heterocyclic group, which may be substituted, X represents a hydrogen atom, a halogen atom, a C.sub.1 -C.sub.5 lower alkyl group, a C.sub.1 -c.sub.5 lower alkoxy group, a C.sub.7 -C.sub.9 arylalkoxy group, a hydroxyl group, a nitro group, or an ester group, and n is an integer of 2 to 10 and salts thereof.

  一种适用于用作精神药物组合物的苯并噁唑啶衍生物，其化学式为：##STR1## 其中A和B均为羰基，或其中一个代表亚甲基，另一个代表羰基，R代表芳香基或杂环基，可以被取代，X代表氢原子、卤原子、C.sub.1-C.sub.5低烷基、C.sub.1-C.sub.5低烷氧基、C.sub.7-C.sub.9芳基烷氧基、羟基、硝基或酯基，n为2至10的整数及其盐。
• Piperazinoisothiazolones with psychotropic activity
  申请人：American Home Products Corporation

  公开号：US04732984A1

  公开（公告）日：1988-03-22

  There are disclosed compounds of the formula ##STR1## wherein R.sup.1 and R.sup.2 are each, independently, hydrogen, lower alkyl, aryl or halo, or R.sup.1 and R.sup.2 taken together represent --CH.sub.2 --, --CH.sub.2 CH.sub.2 --, --O--, --NH--, ##STR2## where the dotted lines represent optional double bonds; R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are each, independently, hydrogen, lower alkyl, aryl or halo; R.sup.7 is 2-pyridinyl, 2-pyrimidinyl, 2-pyrazinyl, 3-pyridazinyl or phenyl or any of the foregoing R.sup.7 moieties substituted by lower alkyl, trifluoromethyl, cyano, nitro or halo, with the proviso that when R.sup.1 and R.sup.2 taken together represent ##STR3## then R.sup.7 is other than 2-pyridinyl, 2-pyrimidinyl or substituted pyrimidin-2-yl; Z is --(CH.sub.2).sub.n --, vinylene, --O--, or ##STR4## X is lower alkylene, vinylene, O or NH; m is 2-5; n is 0-4; o is 1-3; p is 1-4; and the pharmaceutically acceptable salts thereof, and their use as antipsychotic/anxiolytic agents having a low liability for extrapyramidal side effects.

  已公开的化合物的结构式如下：其中R.sup.1和R.sup.2分别独立地表示氢、较低的烷基、芳基或卤素，或者R.sup.1和R.sup.2一起表示--CH.sub.2 --、--CH.sub.2 CH.sub.2 --、--O--、--NH--、##STR2## 其中虚线表示可选的双键；R.sup.3、R.sup.4、R.sup.5和R.sup.6分别独立地表示氢、较低的烷基、芳基或卤素；R.sup.7是2-吡啶基、2-嘧啶基、2-吡嗪基、3-吡啉基或苯基，或者上述R.sup.7基团之一被较低的烷基、三氟甲基、氰基、硝基或卤素取代，但当R.sup.1和R.sup.2一起表示##STR3## 时，R.sup.7不是2-吡啶基、2-嘧啶基或取代的嘧啶-2-基；Z是--(CH.sub.2).sub.n --、乙烯基、--O--或##STR4## X是较低的烷基、乙烯基、O或NH；m为2-5；n为0-4；o为1-3；p为1-4；以及其药学上可接受的盐，以及它们作为具有低额外锥体副作用风险的抗精神病/抗焦虑药物的用途。
• Novel compounds and their use
  申请人：——

  公开号：US20020147200A1

  公开（公告）日：2002-10-10

  A compound of the general formula (I): 1 wherein R 1 , R 2 , X, Y and Z are as described in the specification.

  通式（I）的化合物：其中R1、R2、X、Y和Z如规范中所述。
• Synthesis and structure-activity relationship of substituted tetrahydro- and hexahydro-1,2-benzisothiazol-3-one 1,1-dioxides and thiadiazinones: potential anxiolytic agents
  作者：Magid Abou-Gharbia、John A. Moyer、Usha Patel、Michael Webb、Guy Schiehser、Terrance Andree、J. Thomas Haskins

  DOI：10.1021/jm00125a016

  日期：1989.5

  Several novel substituted tetrahydro- and hexahydro-1,2-benzisothiazol-3-one 1,1-dioxides and thiadiazinones were prepared and examined in a series of in vitro and in vivo tests to determine their pharmacological profile. Most compounds were orally active in blocking the conditioned avoidance response (CAR) but did not antagonize apomorphine-induced stereotyped behavior. Several compounds demonstrated

  制备了几种新颖的取代的四氢-和六氢-1,2-苯并噻唑-3-一和1,1-二氧化物和噻二嗪酮，并在一系列体外和体内试验中进行了研究，以确定它们的药理作用。大多数化合物在阻止条件性回避反应（CAR）方面具有口服活性，但不能拮抗阿扑吗啡引起的刻板印象。几种化合物对5-HT1A受体的结合位点表现出中等至高的亲和力，其中含有2-嘧啶基哌嗪基和[3-（三氟甲基）苯基]哌嗪基部分的化合物37和38和含有2-吡嗪基哌嗪基部分的化合物47表现出最高的亲和力（ Ki值分别为10、4和9 nM。化合物37，3- [4- [4-（2-嘧啶基）-1-哌嗪基]丁基]六氢-4，7-乙炔基-1H-环丁[[f] -1,2-苯并噻唑-3（2H）- 1,1-二氧化物 丁螺环酮和ipsapirone的神经化学和行为特征相似。它们在阻断CAR方面的功效相似，AB50分别为39、32和42 mg / kg。他们还显示了对5-HT1A受体位点的高亲和力和选择性（Ki
• New Antihistamines: Substituted Piperazine and Piperidine Derivatives as Novel H1-Antagonists
  作者：Magid Abou-Gharbia、John A. Moyer、Susan T. Nielsen、Michael Webb、Usha Patel

  DOI：10.1021/jm00020a018

  日期：1995.9

  agents led to the synthesis of compound 8, 2-[4-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]-4, 4a,5,5a,6,6a-hexahydro-4,6-ethenocycloprop[f]isoindole-1,3(2H,3 aH)-dione, which demonstrated good H1-antagonist activity. Substitution of a xanthinyl moiety for the polycyclic imide group led to the identification of novel xanthinyl-substituted piperazinyl and piperidinyl derivatives with potent antihistamine

  多环哌嗪基酰亚胺5-羟色胺能剂的结构操纵导致化合物8、2- [4- [4- [双（4-（氟代苯基）甲基] -1-哌嗪基] -4]，4a，5、5a，6、6a的合成-六氢-4,6-乙炔环丙[f]异吲哚-1,3（2H，3 aH）-二酮，具有良好的H1拮抗剂活性。用黄嘌呤基部分取代多环酰亚胺基团导致鉴定出具有强抗组胺H1活性而没有8的不希望的抗多巴胺能活性的新型黄嘌呤基取代的哌嗪基和哌啶基衍生物。一种化合物24、7- [3- [4-] （二苯甲氧基）-1-哌啶基]丙基]-3,7-二氢-1,3-二甲基-1H-吡啶-2,6-二酮（WY-49051）是一种有效的口服活性H1拮抗剂，具有较长的持续时间和良好的中枢神经系统特征。